However, the treatment of the two diseases is very different, as anti-TNF therapy is the first choice for DADA2 disease (5), while PAN therapy is commonly used in combination with corticosteroids and immunosuppressants. The gene discussed is TNF; the disease is polyarteritis nodosa.